What is Omeros's EPS (diluted)?

Omeros (OMER) reported EPS (diluted) of -$0.59 in Q2 2023.

How has Omeros's EPS (diluted) changed year-over-year?

Omeros's EPS (diluted) decreased by 20.4% year-over-year, from -$0.49 to -$0.59.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Omeros OMER EPS (Diluted)

Discontinued — last reported Q2 '23

EPS (Diluted) at other companies

Cullinan Therapeutics, Inc.CGEM

-$0.69+24.2%

Nektar TherapeuticsNKTR

-$1.82+49.7%

ImmunomeIMNM

-$0.48+7.7%

Vor BiopharmaVOR

-$5.11+1.9%

AnnexonANNX

-$0.23+37.8%

Arcus BiosciencesRCUS

-$1.02+10.5%

Other financials

Income statement

See full

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

Balance sheet

See full

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

See full

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

See full

Market cap$775.86M+313%

P/S8.6×—

Profitability

See full

Gross margin98.9%—

Operating margin-181.8%—

Net margin-136.6%—

FCF margin-121.6%—

Returns & leverage

See full

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Omeros’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Omeros's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omeros's EPS (diluted)?: Omeros (OMER) reported EPS (diluted) of -$0.59 in Q2 2023.
How has Omeros's EPS (diluted) changed year-over-year?: Omeros's EPS (diluted) decreased by 20.4% year-over-year, from -$0.49 to -$0.59.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.